The latest prostate cancer news

Research supports early use of LuPSMA in prostate cancer
Peter Mac researchers have shown LuPSMA therapy can be safely used as a first-line treatment…
The latest prostate cancer news
Peter Mac researchers have shown LuPSMA therapy can be safely used as a first-line treatment…
Led by Joaquin Mateo, Principal Investigator of the Vall d’Hebron Institute of Oncology’s (VHIO) Prostate Cancer…
Epigenetic changes can cause prostate cancer to resist treatment by switching genes on or off.…
On November 16, 2023, the US Food and Drug Administration approved enzalutamide (Xtandi, Astellas Pharma…
Our DNA is not indestructible. Throughout the course of our lives, DNA can break in…
New research from scientists at VCU Massey Comprehensive Cancer Center and the VCU Institute of…
More equitable testing for prostate cancer risk is on the horizon, as researchers report findings…
Researchers at Weill Cornell Medicine, USA, have led a phase 1 trial of a new…
Black men in the United States are more likely to develop prostate cancer than white…
The data from the Phase III PSMAfore trial was presented at the 2023 European Society…